» Articles » PMID: 14969751

Lectin-mediated Drug Targeting: History and Applications

Overview
Specialty Pharmacology
Date 2004 Feb 19
PMID 14969751
Citations 90
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this paper is to review the history of using lectins to target and deliver drugs to their site of action. The hour of birth of "lectinology" may be defined as the description of the agglutinating properties of ricin, by Herrmann Stillmark in 1888, however, the modern era of lectinology began almost 100 years later in 1972 with the purification of different plant lectins by Sharon and Lis. The idea to use lectins for drug delivery came in 1988 from Woodley and Naisbett, who proposed the use of tomato lectin (TL) to target the luminal surface of the small intestine. Besides the targeting to specific cells, the lectin-sugar interaction can also been used to trigger vesicular transport into or across epithelial cells. The concept of bioadhesion via lectins may be applied not only for the GI tract but also for other biological barriers like the nasal mucosa, the lung, the buccal cavity, the eye and the blood-brain barrier.

Citing Articles

Emerging Perspectives on Prime Editor Delivery to the Brain.

BenDavid E, Ramezanian S, Lu Y, Rousseau J, Schroeder A, Lavertu M Pharmaceuticals (Basel). 2024; 17(6).

PMID: 38931430 PMC: 11206523. DOI: 10.3390/ph17060763.


Recent Progress in the Oral Delivery of Therapeutic Peptides and Proteins: Overview of Pharmaceutical Strategies to Overcome Absorption Hurdles.

Mehrotra S, Kalyan Bg P, Nayak P, Joseph A, Manikkath J Adv Pharm Bull. 2024; 14(1):11-33.

PMID: 38585454 PMC: 10997937. DOI: 10.34172/apb.2024.009.


Genetically Encoded Boronolectin as a Specific Red Fluorescent UDP-GlcNAc Biosensor.

Zhang J, Li Z, Pang Y, Fan Y, Ai H ACS Sens. 2023; 8(8):2996-3003.

PMID: 37480329 PMC: 10663054. DOI: 10.1021/acssensors.3c00409.


Photodynamic therapy, priming and optical imaging: Potential co-conspirators in treatment design and optimization - a Thomas Dougherty Award for Excellence in PDT paper.

De Silva P, Saad M, Thomsen H, Bano S, Ashraf S, Hasan T J Porphyr Phthalocyanines. 2023; 24(11n12):1320-1360.

PMID: 37425217 PMC: 10327884. DOI: 10.1142/s1088424620300098.


Experimental models of gut-first Parkinson's disease: A systematic review.

Videlock E, Xing T, Yehya A, Travagli R Neurogastroenterol Motil. 2023; 35(8):e14604.

PMID: 37125607 PMC: 10524037. DOI: 10.1111/nmo.14604.